Randomized Trial Of Platelet Transfusion Policies After Blood Stem Cells Transplantation In Young Children: Reduction Of Number Of Single Platelet Concentrate Donors Per Child
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00180986|
Recruitment Status : Unknown
Verified September 2005 by Gustave Roussy, Cancer Campus, Grand Paris.
Recruitment status was: Active, not recruiting
First Posted : September 16, 2005
Last Update Posted : December 14, 2005
|Condition or disease||Intervention/treatment||Phase|
|Children Treated With High-Dose Chemotherapy (HDC) Followed by Haematopoietic Stem Cell Transplantation (HSCT)||Procedure: Platelet concentrates||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||120 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Randomized Trial Of Platelet Transfusion Policies After Blood Stem Cells Transplantation In Young Children: Reduction Of Number Of Single Platelet Concentrate Donors Per Child|
|Study Start Date :||October 1995|
- The primary end point of the study was tocompare the number of platelet concentrates donors who were implicated in platelet transfusion supportive after HSCT.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00180986
|Villejuif, France, 94800|
|Principal Investigator:||Valérie LAPIERRE, MD||Gustave Roussy, Cancer Campus, Grand Paris|